|
|
Volumn , Issue , 2014, Pages e228-e238
|
|
Improving outcomes in metastatic clear cell renal cell carcinoma by sequencing therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AXITINIB;
EVEROLIMUS;
IMIDAZOLE DERIVATIVE;
INDAZOLE DERIVATIVE;
RAPAMYCIN;
ANALOGS AND DERIVATIVES;
CARCINOMA, RENAL CELL;
HUMAN;
KIDNEY NEOPLASMS;
METASTASIS;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
PATIENT SELECTION;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, RENAL CELL;
HUMANS;
IMIDAZOLES;
INDAZOLES;
KIDNEY NEOPLASMS;
MOLECULAR TARGETED THERAPY;
NEOPLASM METASTASIS;
PATIENT SELECTION;
SIROLIMUS;
TREATMENT OUTCOME;
|
|
EID: 84925293214
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2014.34.e228 Document Type: Review |
|
Times cited : (12)
|
|
References (0)
|